Vivimed Labs (NSE:VIVIMEDLAB) FFO


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
33 GF Score
Price ₹5.71
GF Value ₹2.57
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs FFO?

FFO (Funds from operations) only applies to REITs.

NSE:VIVIMEDLAB
33GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.71 is trading 122.2% above its estimated GF Value™ of ₹2.57. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • FFO:
  • GF Value™: ₹2.57 vs. price of ₹5.71 (122.2% above fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
33GF Score

Get the complete analysis for NSE:VIVIMEDLAB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.71
Price
₹2.57
GF Value